Skip to main content

Find Clinical Trials

Home
Conditions
Nevi and Melanomas

Clinical trial condition

Nevi and Melanomas

Explore clinical trials studying Nevi and Melanomas. Study availability and eligibility vary by location and protocol.

2,362 public trials 405 recruiting studies

Refine in advanced search Browse all conditions

Nevi and Melanomas trial results

Recruiting

DermaSensor Postmarket Surveillance Study

NCT06666790

Conditions: Melanoma, Melanoma, Skin, Neoplasms, +10 more
Locations: Velocity New Smyrna Beach, Florida, United States

West Clinical Research Morehead City, North Carolina, United States

View Trial Details

Recruiting

Study of the Efficacy of Intratumoral L19IL2 or L19TNF or L19IL2/L19TNF, in Combination with Pembrolizumab, in Unresectable Melanoma Patients

NCT06284590

Conditions: Melanoma, Melanoma Stage III, Melanoma Stage IV, +11 more
Locations: Memorial Sloan Kettering Cancer Center New York, United States

View Trial Details

Recruiting

NeoLIPA: Neoadjuvant LTX-315 in Combination with Pembrolizumab in Resectable Stage III/IV Melanoma

NCT06651151

Conditions: Melanoma, Melanoma Stage IIIB-IV, Neoplasms, +10 more
Locations: Oslo University Hospital Oslo, Norway

View Trial Details

Recruiting

Biomarkers in Immunotherapy of Melanoma

NCT05878977

Conditions: Exosomal mRNA Expression of PD-L1 and IFNγ, Gastrointestinal Microbiome (Bacterial and Viral), Immune Checkpoints Inhibitors, +13 more
Locations: Institute of Oncology Ljubljana Ljubljana, Slovenia

View Trial Details

Recruiting

Impact of Telemonitoring for the Management of Side Effects in Patients with Melanoma, Lung or Renal Cancer, Treated with Immunotherapy Combination of Nivolumab and Ipilimumab or Adjuvant Nivolumab Monotherapy

NCT04605146

Conditions: Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Kidney Diseases, +25 more
Locations: Groupement hospitalier Est - Multidisciplinary oncological platform Bron, France

Hôpital Louis Pradel - Department of Pneumology Bron, France

University hospital of Grenoble Alpes - Department of dermatology Grenoble, France

University hospital of Grenoble Alpes - Department of Medical Oncology Grenoble, France

View Trial Details

Recruiting

Evaluation of Skin Health and QoL in Pts Receiving Anti-PD1/PDL1/CTLA4 or CDK Inhibitors.

NCT05878964

Conditions: Bladder Cancer, Breast Cancer, Breast Diseases, +41 more
Locations: Roberto Iacovelli Roma, Italy

View Trial Details

Recruiting

Artificial Intelligence Based Melanoma Early Diagnosis and Risk Prediction in Children, Adolescents and Young Adults

NCT06621810

Conditions: Artificial Intelligence (AI), Melanoma, Melanoma (Skin Cancer), +12 more
Locations: University of Tübingen Tübingen, Germany

University of Florence Florence, Italy

Hospital Clínic de Barcelona Barcelona, Spain

View Trial Details

Recruiting

Safety and Efficacy of KLS-1 Monotherapy in Malignant Neoplasms

NCT06506643

Conditions: CLL, Chronic Disease, Digestive System Diseases, +41 more
Locations: Medical Centre of Arensia Exploratory Medicine LLC Kyiv, Ukraine

View Trial Details

Recruiting

MELCAYA - Novel Health Care Strategies for Melanoma in Children, Adolescents, and Young Adults - Work Package 3 (WP3)

NCT06602648

Conditions: Melanoma, Melanoma of Skin, Neoplasms, +10 more
Locations: University of Florence Florence, Italy

View Trial Details

Recruiting

Stereotactic Body Radiotherapy in Patients With Rare Oligometastatic Cancers (OligoRARE)

NCT04498767

Conditions: Bladder Cancer, Colon Cancer, Colonic Diseases, +53 more
Locations: Institut Jules Bordet Anderlecht, Belgium

Universitair Ziekenhuis Gent Ghent, Belgium

Gasthuiszusters Antwerpen - Sint-Augustinus Wilrijk, Belgium

Centre Oscar Lambret Lille, France

View all 13 locations

View Trial Details